Recent Articles from Investor Brand Network

A federal judge has ruled that health insurance providers in New Mexico aren’t legally required to pay for medical cannabis, even though some state laws suggest they should. This decision underscores the ongoing clash between state-level cannabis initiatives and overarching federal drug policies.

HealthLynked (OTCQB: HLYK) today announced a major enhancement to its appointment booking capabilities, further expanding patient access to care across its growing network of healthcare providers. “At HealthLynked, our mission is to connect patients with the best possible healthcare, faster and more efficiently,” said Dr. Michael Dent, CEO of HealthLynked. “These latest enhancements expand access to care — whether through in-network booking, concierge appointment requests, or specialty-based provider matching. Just as importantly, our new provider review system gives patients real feedback from other users, helping them make better, more confident decisions about their healthcare. Together, these improvements strengthen the patient experience and drive better health outcomes.”

LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0), has begun the permitting process to extract a 100,000-tonne surface bulk sample from its Swanson Gold Deposit in Quebec’s Abitibi Gold Belt. The mineralized material will be processed at LaFleur’s 100%-owned, fully permitted Beacon Gold Mill, located 50 km away. If deemed viable, the results will support a scoping study evaluating future production. The company aims to generate near-term cash flow while advancing exploration, with mill restart and gold production targeted by year-end 2025. Swanson currently hosts an indicated resource of 123,400 oz Au and inferred resource of 64,500 oz Au.

Freight Technologies, Inc. (Nasdaq: FRGT) has entered into a convertible note agreement for up to $20 million with an institutional investor, earmarking proceeds to purchase Official Trump Tokens ($TRUMP) as a core part of its crypto treasury. The initial $1 million tranche supports Fr8Tech’s broader digital asset diversification following its recent $8 million investment in FET tokens. CEO Javier Selgas framed the move as aligned with Fr8Tech’s mission to strengthen U.S.–Mexico commerce and champion balanced, tech-driven trade relationships.

Datavault AI (NASDAQ: DVLT) unveiled a series of 3D NFT Easter eggs at the White House Historical Association’s Easter brunch, combining holographic and blockchain-secured technologies to promote education on U.S. National Parks and endangered species. Through its VerifyU platform, the company minted three full sets of 47 digital eggs, each featuring interactive visuals, conservation history, and tamper-proof Web 3.0 security powered by the Chia blockchain. The initiative, backed by DVHolo displays and ADIO® cryptoanchor tech, reinforces Datavault AI’s mission to merge experiential learning with secure, collectible digital assets.

Onar (OTCQB: ONAR) announced the appointment of marketing pioneer Jon Bond to its board of directors. Bond, co-founder of Kirshenbaum & Bond and former CEO of Big Fuel, brings decades of experience in creative, digital, and programmatic media, having held leadership roles at top firms including Publicis and Inuvo (NYSE: INUV). His addition is expected to enhance ONAR’s M&A strategy, agency network growth, and brand credibility, reinforcing the company’s mission to redefine modern marketing through innovation and strategic expansion.

Energy Fuels (NYSE American: UUUU) (TSX: EFR) reported record uranium mining rates at its Pinyon Plain mine in April, extracting 4,604 tons of ore containing approximately 151,400 pounds of uranium at an average grade of 1.64% eU₃O₈. This marks the highest monthly production since mining began and suggests significantly greater uranium yields than previously estimated. The company also released promising drill results from the Juniper Zone, including intercepts as high as 20.11% eU₃O₈. CEO Mark Chalmers stated these results could lead to increased reserves, lower costs and position Pinyon Plain as the leading U.S. uranium mine in the coming years.

TransCode Therapeutics (NASDAQ: RNAZ) reported continued progress in its Phase 1a trial of TTX-MC138, an RNA-based therapeutic targeting microRNA-10b in metastatic cancer. Thirteen patients have received at least one dose across four dosing levels, with no significant toxicities observed. Eight patients remain in the trial, with two showing stable disease after seven months. Early PK/PD data indicate target engagement and a dose-response relationship consistent with preclinical findings. The results support advancing the trial to Phase 1b for expanded safety and anti-tumor activity evaluation.

ESGold (CSE: ESAU) (OTCQB: ESAUF) has appointed veteran mining executive and former global investment banker Peter Espig to its board of directors, as the company advances its fully permitted Montauban Gold-Silver Project in Quebec toward 2025 production. Espig brings decades of leadership across capital markets and mining operations, including a turnaround success as CEO of Nicola Mining. His appointment comes as ESGold focuses on production readiness, economic reassessment, 3D geological modeling and expanded exploration at Montauban.

NRx Pharmaceuticals (NASDAQ: NRXP) announced it has received a $4.3 million New Drug Application filing fee waiver from the FDA for NRX-100, its preservative-free ketamine therapy for suicidal depression. The waiver, granted to small businesses and drugs deemed essential for public health, enables NRx to complete its NDA by the end of Q2 2025 using existing resources. NRX-100 offers a single-patient ketamine formulation without benzethonium chloride, a preservative associated with neurotoxicity. The company aims to secure FDA approval to provide insurance-covered treatment options beyond current off-label use.

Scinai Immunotherapeutics (NASDAQ: SCNI) will host a webinar May 7 at 11:30 a.m. EST to discuss the treatment potential of Pincell’s novel monoclonal antibody, PC111, for rare skin conditions Pemphigus Vulgaris and SJS/TEN. The session will cover unmet medical needs, PC111’s mechanism targeting soluble Fas ligand, and development plans. The event follows Scinai’s March agreement to acquire Pincell and a related €12 million grant application under Poland’s FENG program. Panelists include executives from Scinai and Pincell, with a live Q&A segment.

Several major carmakers have urged the U.S. Congress to override a 2035 electric vehicle mandate set by California. As the largest electric vehicle market in the U.S. and the world, California has set an incredibly ambitious target of banning the sale of internal combustion engine cars by 2035. Nearly a dozen other states in the United States have adopted similar electric vehicle mandates and put carmakers operating in the country on a path to electrifying most of their vehicle lineups.

The transition to clean energy continues to gain traction globally with more countries shifting from fossil fuels to renewable sources of energy like wind and solar in an effort to reduce greenhouse gas emissions. This transition is reliant on critical metals like copper, cobalt, nickel, and lithium, which are crucial components of infrastructure like solar panels, wind turbines, electric cars, and other clean energy tech.

A team of researchers based at the Amsterdam University Medical Center (UMC) have come up with a new test that can diagnose bacterial meningitis rapidly and with a high degree of accuracy. The test is conducted on cerebrospinal fluid and levels of a protein called CRP are measured. This same protein is also currently relied upon when diagnosing many other bacterial infections.

The White House recently announced it had received over 10,000 public responses regarding its upcoming strategy on AI. The Office of Science and Technology Policy (OSTP) released the collected responses in a massive 18,480-page document. This overwhelming feedback highlights the intense public and industry interest in AI as the global competition to lead in the field heats up.

Nightfood Holdings (OTCQB: NGTF) has named Jimmy Chan as Chief Executive Officer and Ried Floco as President and Director, marking a major leadership transition aimed at accelerating the company’s growth in AI-powered hospitality automation and hotel operations. Chan brings capital markets and supply chain expertise, while Floco adds decades of hospitality leadership, including oversight of over 200 hotel properties. The appointments follow recent acquisitions of Skytech Automated Solutions and CarryOutSupplies.com, positioning Nightfood for vertically integrated expansion in the tech-enabled hospitality space.

The development of treatments for rare diseases remains one of the most pressing challenges in modern medicine. Despite significant advancements in healthcare, many rare diseases still have no approved treatments, and patients often face grim prospects. The market for treatments in this space is substantial, as rare diseases collectively affect millions of people worldwide. Among those working tirelessly to fill these gaps is Soligenix (NASDAQ: SNGX), a biopharmaceutical company that is leading the way with innovative therapies for rare and difficult-to-treat diseases, particularly early-stage cutaneous T-cell lymphoma, a rare form of cancer that affects the skin.

HeartBeam (NASDAQ: BEAT) will host a conference call on May 13 at 4:30 p.m. Eastern to discuss financial results for the first quarter ended March 31, 2025. CEO Robert Eno and CFO Timothy Cruickshank will lead the call, which will include updates on regulatory progress, commercial-readiness efforts, and upcoming milestones. A corresponding press release and presentation will be available on the company’s investor relations website.

Foremost Clean Energy (NASDAQ: FMST) (CSE: FAT) announced a uranium discovery at its Hatchet Lake project in Saskatchewan’s Athabasca Basin, with drill hole TF-25-16 intersecting 0.10% eU₃O₈ over 6.5 meters. The mineralization lies within a 15-meter alteration zone and is open along and across strike. This marks the first field program under Foremost’s option agreement with Denison Mines and highlights the value of leveraging Denison’s historical exploration to prioritize high-potential targets. The ongoing winter drill campaign will now focus on follow-up work and additional targets defined through prior geophysics.

Brera Holdings (NASDAQ: BREA) reaffirmed its commitment to a sustainable, community-focused multi-club ownership model, drawing parallels to trends highlighted in a recent Wall Street Journal article on the rise of U.S.-led football investments. The Company emphasized its strategic acquisition of Juve Stabia, now contending for Serie A promotion, as a prime example of its ladder-climbing approach. As the first publicly traded MCO group, Brera promotes long-term value creation by integrating local engagement, operational discipline, and public market transparency across its expanding global portfolio.

First Tellurium (CSE: FTEL) (OTCQB: FSTTF) announced that its majority-owned subsidiary, PyroDelta Energy, has completed over 800 miles of successful road testing for its thermoelectric generator/radiator, which uses tellurium to convert waste heat into electricity. The device, which replaces both the alternator and radiator in combustion engine vehicles, features no moving parts, improves fuel efficiency, and can be installed without modifying vehicle designs. CEO Tyrone Docherty said the results exceeded expectations, and Head Engineer Michael Abdelmaseh highlighted its adaptability for both new and existing vehicles. The company also noted potential applications in data centers and EVs. A shareholder luncheon will be held May 21 in Vancouver to discuss the innovation and exploration plans at the Deer Horn property.

Nicola Mining (TSX.V: NIM) (OTCQB: HUSIF) is a junior resource company focused on monetizing high-grade mineral assets in British Columbia. With a unique dual-pronged model, the company combines solid operational revenues from its wholly-owned, state-of-the-art gold and silver mill with the long-term upside of 100%-owned copper, silver, and gold exploration projects. This approach allows Nicola to fund ongoing development while minimizing equity dilution.

The crypto sector is entering a potentially transformative phase as the U.S. SEC welcomes new leadership under Paul Atkins. His appointment signals a clear break from past regulatory practices, with promises of fairness, transparency, and a more structured approach to digital asset oversight.

Dating apps have been a big part of modern love stories for years. But now, many people are starting to give up on them. From emotional burnout to safety concerns, dating online isn’t what it used to be. As a result, even the biggest dating platforms are seeing fewer users, and even less profit.

Energy prices in the United Kingdom (UK) are on the rise despite a nationwide increase in renewable energy generation. A recent announcement by regulator Ofgem has revealed that the average UK family is spending 6% more on energy bills this month, forcing thousands of homes to dig deeper into their pockets even though the UK is producing more clean energy than ever.

Cybin (NYSE American: CYBN) (NEO: CYBN) announced that CEO Doug Drysdale will speak at the 28th Annual Milken Institute Global Conference on May 5 at 2:30 p.m. PDT. He will join the panel “The Global Landscape and Opportunities for Medical Breakthroughs” to discuss innovation in drug development and next-generation mental health treatments. The event will be held at the Beverly Hilton in Los Angeles, with a live stream and replay available via Cybin’s investor website.

Marijuana businesses operating legally across different states face a complicated reality when it comes to product testing . Without federal regulations, states have built their own rules around lab licensing, testing requirements, sampling methods, and even how to handle contaminated products.

Monogram Technologies (NASDAQ: MGRM), an AI-driven robotics company transforming orthopedic surgery, has received approval from India’s Central Drugs Standard Control Organization to import its mBôs TKA system and begin a 102-patient, multi-center clinical trial in partnership with Shalby Limited (NSE: SHALBY). The study will evaluate the safety and effectiveness of Monogram’s robotic total knee replacement system using a Consensus CKS implant and include three-month clinical follow-up across multiple Indian sites. Monogram will deploy full-time staff to support training and execution, with surgeries expected to begin within 90 business days. CEO Benjamin Sexson called the approval a major milestone toward commercial launch, while partners from Reliance Life Sciences and Shalby praised the trial’s potential to elevate global orthopedic standards.

Nicola Mining (TSX.V: NIM) (OTCQB: HUSIF) is a junior resource company focused on monetizing high-grade mineral assets in British Columbia. The company leverages a unique dual-pronged operational strategy combining solid revenues from its wholly owned, state-of-the-art gold and silver mill with the long-term upside of 100%-owned copper, silver, and gold exploration projects. This approach allows the company to fund ongoing development while minimizing equity dilution.

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a Swiss-hosted cybersecurity and privacy communications platform, has closed the first tranche of its non-brokered private placement, raising gross proceeds of CA$105,000. The company issued 3 million units at CA$0.035 each, with each unit consisting of one common share and one full warrant exercisable at CA$0.05 for 24 months. No finders’ fees were paid. Sekur plans to use the proceeds to support U.S. marketing efforts for its privacy communications solutions and for general working capital.

Cancer remains one of the deadliest diseases worldwide. Globally, the World Health Organization reports that the number of deaths will surpass 9.7 million in 2024, with a projected 20 million new cancer cases diagnosed; WHO also noted that it anticipates the cancer burden increasing an estimated 77% by 2050 ( https://ibn.fm/VfZlY ). These numbers underscore the urgency of ongoing cancer research and the need for more effective cancer treatments.

Switching to an electric car often seems like an incredibly costly endeavor. The average battery electric vehicle (BEV) costs around $10,000 to $15,000 more than a comparable gasoline-powered car, and most EV owners also install home chargers, making the initial price of electric vehicle ownership significantly higher. Fortunately, switching your gas-powered car for an electric alternative can save you a surprising amount of money over time.

Last week saw the price of gold slip below $3,300 to hit $3,294, representing a more than 1.6% loss. This comes as the trade war between America and China continues and volatility in the market triggers mixed sentiments between traders.

A team of researchers has leveraged a technique called temporal learning to train an AI system to predict the likelihood of brain cancer recurring in kids diagnosed with gliomas. This AI model uses the magnetic resonance images periodically captured after the kids have received treatment for the gliomas.

OpenAI, the company behind ChatGPT, has shown interest in acquiring Chrome —the world’s most widely used web browser—if Google were ever required to sell it. Nick Turley, a senior OpenAI executive, revealed this during testimony supporting the U.S. government’s antitrust case against Google.

Nutriband (NASDAQ: NTRB) has released a shareholder letter from CEO Gareth Sheridan outlining key achievements in 2024 and plans for 2025, centered on advancing its AVERSA abuse-deterrent transdermal technology. The company is transitioning from feasibility to commercial development of AVERSA Fentanyl in partnership with Kindeva Drug Delivery, targeting a pivotal Human Abuse Liability clinical trial and NDA filing. AVERSA Fentanyl and AVERSA Buprenorphine could reach peak annual sales of up to $200 million and $130 million respectively. Nutriband also expanded its global patent portfolio to 46 countries and raised $8.4 million in a non-brokered placement. The company expects continued revenue growth in 2025 from its Pocono Pharma subsidiary, driven by its partnership with KT Tape.

Nutriband (NASDAQ: NTRB) is earning widespread recognition for the board’s leadership, expertise and innovation across a variety of platforms. Sheridan has recently been acknowledged in several high-profile ways that affirm his growing influence as a respected professional in the healthcare and business sectors. From being named a finalist for the prestigious EY Entrepreneur of the Year Awards to providing key insights in a BBC News feature on Irish companies operating internationally and sharing their strategic vision in a wide-ranging interview, NTRB’s voice is increasingly shaping discussions around entrepreneurship, innovation and the future of healthcare.

Silo Pharma (NASDAQ: SILO) today announced favorable preclinical results for SP-26, its novel extended-release ketamine implant aimed at treating fibromyalgia. Conducted in minipigs, the study met all endpoints, including safety, tolerability, and pharmacokinetics, with no implant-related adverse events and sustained ketamine release for up to 22 days. CEO Eric Weisblum said the results support SP-26’s advancement as a next-generation, abuse-deterrent pain therapy. Designed for subcutaneous delivery, SP-26 avoids the dissociative effects of IV ketamine and may offer a safer alternative to opioids, potentially becoming the first at-home injectable ketamine-based therapeutic.

Datavault AI (NASDAQ: DVLT), a leader in AI data experience, valuation and monetization, has secured the majority stockholder consent required to finalize its acquisition of CompuSystems Inc. (“CSI”) and mailed an Information Statement on April 29, 2025, under Section 14(c) of the Securities Exchange Act. No stockholder vote is required, and the transaction is expected to close on or about the week of May 19. CSI’s assets and operations will be integrated into Datavault AI, with the acquisition projected to contribute $15 million to $20 million in revenue toward the company’s 2026 goal of $40 million to $50 million. CEO Nathaniel Bradley called the deal a major milestone in Datavault AI’s growth plan and said further details will be shared during a business update call scheduled for May 20 at 9 a.m. ET.

Fifty 1 Labs (OTC: FITY), a leader in technology and wellness innovation, has appointed Michael Lawson as CEO and Chairman while launching its new BioSentry Division focused on advanced biohazard detection. The division will develop real-time sensor systems using PCR, spectrometry and AI-driven analytics to detect biological, chemical and environmental threats, with applications spanning defense, public health, and industrial safety. The company also announced a strategic partnership with UAV Corp (OTC: UMAV) to integrate the sensors with UAVs and plans to issue a UMAV share dividend to FITY shareholders. Meanwhile, Fifty 1 Labs has opted not to proceed with the Genetic Networks acquisition and remains focused on securing Department of Defense contracts. Brandon Spikes and Robert Clark will continue in key leadership roles as the company advances its dual focus on safety and wellness technologies.

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is featured in the latest episode of The MiningNewsWire Podcast, where Co-Founder, Director, President and CEO Frank R. Hallam discusses the company’s flagship Waterberg Project in South Africa. Hallam highlights how the deposit—discovered in 2011—stands apart with its shallow depth and exceptional thickness, enabling safer, more cost-efficient, and highly mechanized mining. Unlike traditional South African platinum operations that rely on deep, labor-intensive shafts, Waterberg allows for decline access and heavy machinery. Hallam also shares insights on Lion Battery Technologies, the company’s joint venture exploring platinum and palladium applications in lithium batteries, as part of Platinum Group Metals’ innovation strategy.

ONAR (OTCQB: ONAR) is a leading marketing technology company and marketing agency network focused on delivering integrated, AI-driven solutions to accelerate revenue growth for its clients. Through an agile agency network specializing in performance marketing, full-service healthcare marketing, experiential marketing, and technology incubation, ONAR provides best-in-class services to a growing roster of clients worldwide.

The price of gold has been setting record after record and many investors are now wondering whether the price of an ounce of this precious metal could reach $4,000 this year. After all, it reached $3,000 in March, and now seems to be comfortable at the $3,300 level with no sign of a major drop. We explore what the prospects of this metal are in 2025 and beyond.

Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM), advancing its Iska Iska silver-tin polymetallic project in southwestern Bolivia, will soon begin a 4,300-meter, eight-hole diamond drilling program targeting the Santa Barbara starter pit area. The campaign is designed to upgrade and expand high-grade tin and silver mineralization, with holes spaced at 50 meters to confirm continuity. CEO Tom Larsen said prior drilling extended mineralization and revealed new targets, contributing to a significantly expanded footprint. The upcoming 2025 phase 1 campaign will further assess the zone’s resource potential to support an updated PEA, with ongoing metallurgical studies showing promising results.

In 2022, a couple, Kim Stetz and her partner Marq Hayes submitted an application for a Conditional Adult-Use Recreational Dispensary (CAURD) license . Their goal was to open an adult-use marijuana store called Brown Budda in New York.

Brera Holdings (NASDAQ: BREA), an Ireland-based, international holding company focused on expanding its global portfolio of men’s and women’s sports clubs through a multi-club ownership (“MCO”) approach, just crossed a significant milestone with S.S. Juve Stabia S.r.l. Dubbed “ The Second Team of Naples ,” Juve Stabia just recorded the highest market value increase in Italy’s Serie B, according to Transfermarkt. This demonstrates Brera’s ownership’s swift impact on the club, pointing to the latter’s growing competitiveness, on and off the pitch.

Better Choice Company (NYSE American: BTTR), a pet health and wellness company, has closed on its public offering. The offering consisted of 639,000 shares of common stock as well as prefunded warrants to purchase 1,028,000 shares of its common stock. According to the announcement, each share of common stock and prefunded warrant was sold at $3 per share (inclusive of the prefunded warrant exercise price), resulting in gross proceeds of approximately $5 million, before underwriting discounts and offering expenses were deducted.

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, is advancing its phase 3 replication study (“FLASH2”) for HyBryte(TM), a novel photodynamic therapy designed to treat early-stage cutaneous T-cell lymphoma (“CTCL”). Building on the success of a prior phase 3 trial, HyBryte(TM)—which uses synthetic hypericin activated by safe visible light—offers a potentially game-changing approach by providing a noninvasive, well-tolerated alternative that targets malignant T-cells with precision. With patient enrollment underway and interim analysis expected in early 2026, the study is designed to potentially meet the stringent requirements of regulatory agencies in order to strengthen the case for HyBryte(TM) as a commercially available treatment. This milestone emphasizes Soligenix’s broader strategy of using innovative therapeutic approaches to tackle rare and difficult-to-treat diseases. The progress of HyBryte(TM) also underscores the importance of photodynamic therapy as a new and effective modality that could potentially be applied to other dermatological and oncological conditions.

Adageis is revolutionizing healthcare with its flexible, AI-centric software solutions and ProActive Care Platform, built to eliminate administrative burdens and enable providers to focus on patients. With simplicity core to its design, the platform empowers healthcare organizations by identifying missed revenue opportunities from insurers and guiding providers to secure rightful payments. Using predictive analytics through its Patented Risk Engine (“PRE”), Adageis enhances steady cash flow by forecasting incentive payments and factoring receivables. The platform seamlessly integrates with over 90 electronic health record systems, minimizing disruption and easing the shift to value-based care. As the healthcare sector continues in this trend, Adageis represents a key player in simplifying financial operations for providers, allowing them to focus on what matters most.

ESGold (CSE: ESAU) (OTCQB: ESAUF) is moving closer to gold and silver production at its Montauban Project in Quebec, with the company now actively exploring funding partnerships with both provincial and federal governments. The focus of these discussions is to secure non-dilutive support that aligns with broader goals of sustainability, innovation, and regional job creation, according to a company press release ( https://ibn.fm/cBRI3 ).

NanoViricides, Inc. (NYSE American: NNVC) provided an update on its Measles drug development program, highlighting the potential of its broad-spectrum antiviral candidate NV-387. With declining vaccination rates raising the risk of measles becoming endemic in the United States, the company emphasized the need for an effective antiviral treatment. NV-387, which has shown success against related viruses like RSV in animal models, is being prepared for an animal study in humanized mice. The candidate has completed Phase I trials with no adverse events and has demonstrated strong antiviral efficacy across multiple viruses that utilize the HSPG infection pathway, providing a rationale for its potential effectiveness against measles.

Tonix Pharmaceuticals (NASDAQ: TNXP) presented positive data supporting TNX-1700, its lead immuno-oncology candidate, at the American Association for Cancer Research (AACR) 2025 Annual Meeting. Preclinical results showed that a fusion protein version of TFF2 significantly reduced immunosuppressive neutrophils and enhanced anti-tumor immune responses in gastric cancer models, especially when combined with anti-PD1 therapy. Tonix is advancing TNX-1700 under a license from Columbia University as part of its strategy to develop treatments targeting the tumor microenvironment in gastric and colon cancers.

The electric vehicle (EV) landscape is undergoing a major transformation, and this time, it’s great news for buyers. Instead of rising prices, the used EV market is seeing record-breaking price drops, sparking a surge in consumer interest.

The United States government is taking steps to protect its domestic solar equipment industry from being overwhelmed by major players from East Asia. Over the past decade, countries in East Asia have significantly boosted solar panel output, becoming some of the largest producers in the world. With the U.S. planning a major transition to renewables, their dominance threatens the survival of America’s domestic solar industry.

The hospitality industry has undergone a major transformation. As travel increases and guest expectations evolve, hoteliers are under more pressure than ever to deliver personalized, seamless and proactive service — all while managing rising costs and operational complexity. This dynamic environment calls for innovation not only to stay competitive but to thrive before smart technology becomes a standard within all hospitality businesses. Nightfood Holdings (OTCQB: NGTF), a forward-thinking holding company, is emerging as a key player driving this change through technology-enabled solutions that are reshaping how the hospitality sector operates in this modernized world.

HeartBeam (NASDAQ: BEAT) announced that its synthesized 12-lead ECG technology met clinical endpoints in the VALID-ECG pivotal study, achieving a 93.4% diagnostic agreement with standard 12-lead ECGs for arrhythmia assessment. Results were presented by Dr. Thomas Deering of Piedmont Heart Institute during the Heart Rhythm Society’s annual conference. HeartBeam’s 3D ECG technology, designed to fit into a credit card-sized device, aims to bring hospital-grade cardiac insights to patients anywhere, with commercialization planned following anticipated FDA clearance.

Annovis Bio (NYSE: ANVS), announced the appointment of Hui Liu as Director of Biostatistics as the company advances its pivotal Phase 3 Alzheimer’s disease trial. Liu brings over 19 years of experience in clinical trial design, analysis and regulatory submission support across multiple therapeutic areas. Annovis stated that Liu’s expertise will help reinforce the scientific integrity of its data and enhance regulatory strategies as it develops transformative therapies for neurodegenerative disorders.

G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) announced results of its feasibility study (“FS”) for the wholly owned Oko West Gold Project in Region 7, Guyana, confirming robust economics for a large-scale open-pit and underground mining operation. The study outlines total production of 4.3 million gold ounces over 12.3 years, with an average annual production of 350,000 ounces at an all-in sustaining cost (“AISC”) of $1,123 per ounce. The project carries an after-tax net present value (“NPV”) of $2.2 billion and a 27% after-tax internal rate of return (“IRR”) based on a $2,500 per ounce gold price. Final environmental permits are expected in Q2 2025, with a construction decision targeted for H2 2025.

SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) announced plans to develop the Glor Rd project, a 7.2 MW DC ground-mount solar installation in upstate New York. With a secured site lease and an interconnection study underway, the project will operate under New York’s VDER rate mechanism and is expected to qualify for NYSERDA NY-Sun Program incentives. Once completed, the project will provide community solar benefits to local residents, offering clean energy access without the need for personal panel installations. Solar Simplified will manage customer-facing activities to support full subscription and maximize revenue.

NextPlat (NASDAQ: NXPL, NXPLW) announced it has received a written notice from Nasdaq Stock Market LLC stating that the company is not in compliance with Nasdaq Listing Rule 5550(a)(2), as its closing bid price has remained below $1.00 per share for 30 consecutive business days. NextPlat has been granted a 180-calendar day period, until Oct. 27, 2025, to regain compliance by maintaining a minimum $1.00 closing bid price for at least 10 consecutive business days. The company may qualify for an additional 180-day extension if it meets other listing requirements. NextPlat stated it is actively pursuing strategies to improve business efficiency and protect shareholder value while considering options to regain compliance.

Cancer remains one of the most formidable health challenges worldwide, necessitating relentless research to uncover effective treatments. Continuous scientific inquiry has led to groundbreaking therapies, offering hope to millions. A recent development in this arena is Calidi Biotherapeutics’ (NYSE American: CLDI) announcement of promising preclinical results for its systemic RTNova platform, highlighting the critical role of research in combating cancer.

North Korean hackers have reportedly managed to create two fake companies in the U.S., slipping past Treasury Department sanctions in an effort to target crypto developers with malware. The companies, Softglide LLC and Blocknovas LLC were registered in New York and New Mexico, respectively, using fake addresses and names.

When crypto prices fall, people often get scared. Investors pull back, and the excitement dies down. Many companies think it’s better to stay quiet until things get better. But in reality, keeping up with public relations (PR) during hard times is actually a smart move that can help them grow stronger.

The United Kingdom (UK) is courting investors attending the Renewable Energy Summit to secure much-needed financing for its burgeoning renewable energy industry. With the United States becoming increasingly hostile to renewables under President Donald Trump’s decidedly anti-green energy strategy, UK leaders are looking to woo investors who might have invested in the American market under more favorable conditions.

Newton Golf Company (NASDAQ: NWTG) announced the launch of its newest shaft family, Newton Fast Motion, now available for purchase at a suggested retail price of $325. The lighter, Tour-proven shaft is engineered to deliver exceptional precision and enhanced swing speed, building on the company’s four core technologies: Elongated Bend Profile, Kinetic Energy Storage, Symmetry 360 Construction and Variable Bend Profile. The Fast Motion series, constructed with advanced high-modulus Toray carbon fibers and featuring a distinctive red-to-gold finish, has already seen adoption by more than 30 professionals across the PGA TOUR Champions and LPGA Tour. Following 887% revenue growth in FY2024, Newton Golf expects the Fast Motion series to further accelerate its momentum in 2025.

The potential shift in how cannabis is classified under federal law is stirring up discussions about the future of the cannabis industry and the possibility of opening up interstate trade. Although many U.S. states have already legalized cannabis for recreational, medical use, or both, it’s still illegal at the federal level, which limits the ability to create a unified national market.

AirJoule Technologies (NASDAQ: AIRJ) announced it has entered into subscription agreements for a $15 million private placement anchored by GE Vernova and other investors to accelerate commercialization of its AirJoule® system, which extracts pure water from air using low-grade waste heat. The net proceeds will fund pilot deployments of the AirJoule® A1000 units in 2025. AirJoule and GE Vernova also launched a strategic project to integrate the technology into GE Vernova’s product offerings for industrial water production.

Brazil Potash (NYSE-American: GRO) announced the appointment of Marcelo Lessa to its advisory board. Lessa, who brings over 30 years of agriculture finance and investment expertise including 16 years at the IFC/World Bank, will support Brazil Potash’s construction financing strategy for its Autazes Project. His extensive experience in securing funding for major agricultural and infrastructure projects is expected to play a key role as the company advances development of its critical mineral potash asset.

BriaCell Therapeutics (Nasdaq: BCTX, BCTXZ) (TSX: BCT) announced the pricing of an underwritten public offering of 3,066,666 units at $4.50 per unit for gross proceeds of approximately $13.8 million. Each unit includes one common share or pre-funded warrant and one warrant exercisable at $5.25 per share. The offering, led by ThinkEquity, is expected to close on April 28, 2025, subject to customary conditions. BriaCell plans to use the net proceeds for working capital, corporate purposes and advancing business objectives.

Europe is making huge progress in clean energy, and solar power is leading the way. New data shows that the continent is on track to break solar power records in 2025, thanks to strong growth in the first few months of the year. With better technology, falling costs, and more countries joining the solar push, Europe is closer than ever to reaching its green energy goals.

An Indian tech startup with the government’s backing has unveiled the first full-stack quantum computing system in India, marking a significant moment in the nation’s advanced research and deep-tech journey and bringing the rapidly expanding Asian economy a step closer to achieving technological self-reliance. During the recent World Quantum Day, Bengaluru-based startup QpiAI introduced QpiAI-Indus, a quantum computer with no equals in India, and propelled the country to the top echelons of quantum computing research.

Datavault AI (NASDAQ: DVLT) highlighted its ADIO® tone technology at NFL Alumni Health’s 16th Annual Draft Week event on April 24, 2025, delivering interactive tones synced with top draft picks and geo-targeted health messages across the venue. The platform enabled real-time fan engagement without screens or manual input and supported cardiovascular health awareness for former athletes. Datavault AI’s deployment demonstrated how AI-powered tone technology can deepen audience interaction and create new monetization opportunities at major live events.

Strategic acquisitions are a cornerstone for companies aiming to scale and diversify, particularly in the hospitality sector, where consumer preferences and technological advancements rapidly evolve. In this dynamic environment, Nightfood Holdings (OTCQB: NGTF) has demonstrated its commitment to savvy acquisitions in the past six months, positioning itself to capitalize on emerging robotic trends and broaden its market presence.

Calidi Biotherapeutics (NYSE American: CLDI) announced the selection of IL15 superagonist (IL15-IL15Ra) as the first therapeutic payload for its systemic antitumor virotherapy platform, RTNova. Preclinical data presented at the AACR Annual Meeting show that Calidi’s engineered vaccinia virus can deliver IL15 superagonist directly into the tumor microenvironment, significantly boosting immune response and tumor elimination while minimizing systemic toxicity. The RTNova platform aims to treat metastatic cancers by enabling systemic delivery of tumor-targeted virotherapies.

Kairos Pharma (NYSE American: KAPA), announced it will present new data on KROS 101, a small molecule GITR ligand agonist, at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. The poster, titled “Effect of KROS 101, a small molecule GITR ligand agonist, on T effector cells, T reg cells and intratumoral CD8 T cell cytotoxicity,” will be presented June 2 at McCormick Place in Chicago. Kairos CEO John Yu, M.D., highlighted the opportunity to share findings and advance discussions around KROS 101’s potential in optimizing cancer treatment.